Plus Therapeutics Inc share price logo

Plus Therapeutics Inc Share Price

NASDAQ: PSTV

Small Cap

$5.28

-0.13

(-2.50%)

Live

as on

Plus Therapeutics Inc Stock Performance

as on April 15, 2026 at 4:09 am IST

  • Day's Low

    Day's High

    $5.21
    $6.03
    downward going graph

    1.33%

    Downside

    14.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.90
    $30.50
    downward going graph

    45.08%

    Downside

    477.65%

    Upside

    downward going graph

Plus Therapeutics Inc share price movements today

Previous Close
$5.41
Open
$6.00
Volume
724.1K
Day's Low - High
$5.21 - $6.03
52 Week Low - High
$2.90 - $30.50

Plus Therapeutics Inc Historical Returns

1 Month Return
-13.44 %
3 Month Return
-25.48 %
1 Year Return
-66.16 %
3 Year Return
-94.8 %
5 Year Return
-99.34 %

Plus Therapeutics Inc Stock Fundamentals & Key Indicators

Check Plus Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.9M

EPS (TTM)

-3.8175

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

2.4504

EBITDA

-14.9M

Revenue (TTM)

5.2M

Profit Margin

0.00%

Return On Equity TTM

-522.50%

Plus Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Plus Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Plus Therapeutics Inc image
Plus Therapeutics Inc
BUY$32.9M-99.34%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B140.76%138.848.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.0B102.67%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA124.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B55.14%18.0531.41%

Stock Returns calculator for Plus Therapeutics Inc Stock including INR - Dollar returns

The Plus Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Plus Therapeutics Inc investment value today

Current value as on today

₹35,720

Returns

-₹64,280

(-64.28%)

Returns from Plus Therapeutics Inc Stock

-₹66,979 (-66.98%)

Dollar Impact

₹2,699 (+2.7%)

Analyst Recommendation on Plus Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Plus Therapeutics Inc. Average target price of $38

Plus Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Plus Therapeutics Inc.

What analysts predicted

86.11%UPSIDE

Target Price

$38

Current Price

$5.28

Analyzed by

10 Analysts

Target

$38.00

Plus Therapeutics Inc target price $38, a slight upside of 86.11% compared to current price of $5.28. According to 10 analysts rating.

Plus Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Plus Therapeutics Inc Shares on INDmoney has grown by 23.52% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:23.52% versus previous 30 day period

Search interest for Plus Therapeutics Inc Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Plus Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
1
1
1
1
1
1
1
1
1
Gross Profit
1
1
1
1
1
1
0
1
1
1
Operating Income
-3
-3
-3
-3
-3
-3
-3
-1
-4
-5
EBITDA
-2
-3
-3
0
-2
-3
-13
5
-4
-2
Interest Expense
0
0
0
3
0
0
3
-
-
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
-3
-2
-2
-3
-17
5
-4
-5
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-3
-3
-3
-2
-2
-3
-17
5
-4
-5
Net Profit Margin
-259.60%
-290.18%
-194.45%
-229.87%
-197.39%
-276.42%
-1643.15%
370.58%
-316.61%
-417.92%

Plus Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
11
6
2
6
0
-
0
4
5
5
Gross Profit
8
5
1
6
-2
0
0
-4
4
4
Operating Income
-19
-20
-8
-3
-9
-12
-19
-13
-14
-15
EBITDA
-18
-18
-6
0
-8
-12
-18
-12
-8
-14
Interest Expense
2
2
1
1
1
0
0
0
3
3
Depreciation
-
2
2
0
0
0
0
0
0
0
Income Before Tax
-22
-22
-8
-3
-8
-13
-20
-13
-12
-22
Income Tax Expense
2
2
1
9
1
0
0
-
-
-
Net Income
-22
-22
-12
-10
-8
-13
-20
-13
-12
-22
Net Profit Margin
-193.73%
-353.86%
-423.53%
-155.57%
-2719.80%
0.00%
-9051.34%
-271.04%
-222.84%
-429.43%

Plus Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
-3
-2
-2
-3
-17
5
-4
-5
Operating Cash Flow
-1
-4
-1
-3
-1
-6
-5
-2
-6
Investing Cash Flow
0
0
-3
0
0
3
-4
1
-1
Financing Cash Flow
0
0
6
-
-
12
2
12
2
Change in Cash
-2
-5
2
-3
-1
9
-7
11
-4

Plus Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-12
-10
-8
-13
-20
-13
-12
-22
Operating Cash Flow
-18
-11
-5
-8
-10
-12
-12
-10
-20
Investing Cash Flow
-1
0
5
0
0
0
0
-4
0
Financing Cash Flow
16
7
12
0
20
13
3
6
30
Change in Cash
-2
-4
12
-9
10
0
-9
-8
8

Global Institutional Holdings in Plus Therapeutics Inc

Funds
Holdings
Scientech Research LLC
0.08%
XTX Topco Ltd
0.14%
Citadel Advisors Llc
0.11%
Mercer Global Advisors Inc.
0.02%
Kestra Advisory Services, LLC
0.01%
See all

Insights on Plus Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PSTV stock has moved up by 85.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.7% return, outperforming this stock by 104.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 158.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.39M → 1.36M (in $), with an average decrease of 2.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 5.15M → -5.71M (in $), with an average decrease of 107.5% per quarter

About Plus Therapeutics Inc

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests comprising the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
OrganisationPlus Therapeutics Inc
Headquarters6420 LEVIT GREEN BOULEVARD, Houston, TX, United States, 77021
IndustryBiotechnology
CEODr. Marc H. Hedrick M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Plus Therapeutics Inc

Name

Title

Mr. Russell W. Bradley

President & GM of CNSide Diagnostics, LLC

Dr. Marc H. Hedrick M.B.A., M.D.

President, CEO & Director

Mr. Russ Havranek M.B.A., M.S.

Executive Vice President of Commercial and Corporate Strategy

Ms. Desiree Smith

Corporate Controller

FAQs

What is Plus Therapeutics Inc share price today?

Plus Therapeutics Inc share price today is $5.28 as on . Plus Therapeutics Inc share today touched a day high of $6.03 and a low of $5.21.

What is the 52 week high and 52 week low for Plus Therapeutics Inc share?

Plus Therapeutics Inc share touched a 52 week high of $30.5 on and a 52 week low of $2.9 on . Plus Therapeutics Inc stock price today i.e. is trending at $5.28,which is 82.69% down from its 52 week high and 82.07% up from its 52 week low.

What is Plus Therapeutics Inc's market capitalisation today?

Plus Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Plus Therapeutics Inc Stock (PSTV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Plus Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Plus Therapeutics Inc Shares that will get you 0.2841 shares as per Plus Therapeutics Inc share price of $5.28 per share as on April 14, 2026 at 10:39 pm IST.

What is the minimum amount required to buy Plus Therapeutics Inc Stock (PSTV) from India?

Indian investors can start investing in Plus Therapeutics Inc (PSTV) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Plus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Plus Therapeutics Inc share’s latest price of $5.28 as on April 14, 2026 at 10:39 pm IST, you will get 1.8939 shares of Plus Therapeutics Inc. Learn more about fractional shares .

What are the returns that Plus Therapeutics Inc has given to Indian investors in the last 5 years?

Plus Therapeutics Inc stock has given -99.34% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?